CerCell collaborate with end-users for product improvement
(Arranged in alphabetic order)
Extensive bioreactor product development project for advanced mammalian cell expression.
The Cell and Gene Therapy Catapult (CGT) was established in 2012 as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialization. Development project for bioreactors for stem cell proliferation.
Extensive bioreactor product development project with Merck / MSD being a major US based pharmaceutical company.